These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 39054625)

  • 21. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re-appraisal of N2 disease by lymphatic drainage pattern for non-small-cell lung cancers: by terms of nodal stations, zones, chains, and a composite.
    Zheng H; Wang LM; Bao F; Jiang GN; Xie HK; Ding JA; Hu XF; Chen C
    Lung Cancer; 2011 Dec; 74(3):497-503. PubMed ID: 21529990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
    Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
    Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New N1/N2 classification and lobe specific lymphatic drainage: Impact on survival in patients with non-small cell lung cancer treated with surgery.
    Tsitsias T; Okiror L; Veres L; King J; Harrison-Phipps K; Routledge T; Pilling J; Bille A
    Lung Cancer; 2021 Jan; 151():84-90. PubMed ID: 33250210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience.
    Ruffini E; Filosso PL; Bruna MC; Coni F; Cristofori RC; Mossetti C; Solidoro P; Oliaro A
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1037-44. PubMed ID: 19692259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Prognostic Significance of Metastasis to Lymph Nodes in Aortopulmonary Zone (Stations 5 and 6) in Completely Resected Left Upper Lobe Tumors.
    Citak N; Sayar A; Metin M; Büyükkale S; Kök A; Solak O; Yurt S; Gürses A
    Thorac Cardiovasc Surg; 2015 Oct; 63(7):568-76. PubMed ID: 25893919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the N Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer.
    Huang J; Osarogiagbon RU; Giroux DJ; Nishimura KK; Bille A; Cardillo G; Detterbeck F; Kernstine K; Kim HK; Lievens Y; Lim E; Marom E; Prosch H; Putora PM; Rami-Porta R; Rice D; Rocco G; Rusch VW; Opitz I; Vasquez FS; Van Schil P; Jeffrey Yang CF; Asamura H;
    J Thorac Oncol; 2024 May; 19(5):766-785. PubMed ID: 37866624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcomes of upfront surgery in patients with resectable pathological N2 non-small-cell lung cancer.
    Yun JK; Bok JS; Lee GD; Kim HR; Kim YH; Kim DK; Park SI; Choi S
    Eur J Cardiothorac Surg; 2020 Jul; 58(1):59-69. PubMed ID: 32155245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the proposed classifications for the revision of N descriptors for non-small-cell lung cancer.
    Lee GD; Kim DK; Moon DH; Joo S; Hwang SK; Choi SH; Kim HR; Kim YH; Park SI
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):580-8. PubMed ID: 25890940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
    Matsunaga T; Suzuki K; Takamochi K; Oh S
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic value of lymph node dissection for right middle lobe non-small-cell lung cancer.
    Kuroda H; Sakao Y; Mun M; Motoi N; Ishikawa Y; Nakagawa K; Yatabe Y; Okumura S
    J Thorac Dis; 2016 May; 8(5):795-802. PubMed ID: 27162652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis.
    Eichhorn F; Klotz LV; Muley T; Kobinger S; Winter H; Eichhorn ME
    Lung Cancer; 2019 Dec; 138():95-101. PubMed ID: 31678832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-station skip-N2 disease: good prognosis in resected non-small-cell lung cancer (long-term results in skip-N2 disease).
    Yazgan S; Ucvet A; Gursoy S; Samancilar O; Yagci T
    Interact Cardiovasc Thorac Surg; 2019 Feb; 28(2):247-252. PubMed ID: 30085065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical outcomes after initial surgery for clinical single-station N2 non-small-cell lung cancer.
    Hishida T; Yoshida J; Ohe Y; Aokage K; Ishii G; Nagai K
    Jpn J Clin Oncol; 2014 Jan; 44(1):85-92. PubMed ID: 24203815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New revisions and current issues in the eighth edition of the TNM classification for non-small cell lung cancer.
    Hattori A; Takamochi K; Oh S; Suzuki K
    Jpn J Clin Oncol; 2019 Jan; 49(1):3-11. PubMed ID: 30277521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
    Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F
    Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients.
    Bille A; Woo KM; Ahmad U; Rizk NP; Jones DR
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):674-679. PubMed ID: 28200091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of N1 and N2 surgery in non-small cell lung cancer].
    Pfannschmidt J; Kollmeier J
    Chirurg; 2019 Dec; 90(12):974-981. PubMed ID: 31501934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.